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Abstract
Fragile X-associated tremor/ataxia syndrome (FXTAS), a late-onset neurodegenerative disorder, has been recognized in
older male fragile X premutation carriers and is uncoupled from fragile X syndrome. Using a Drosophila model of FXTAS, we
previously showed that transcribed premutation repeats alone are sufficient to cause neurodegeneration. MiRNAs are
sequence-specific regulators of post-transcriptional gene expression. To determine the role of miRNAs in rCGG repeat-
mediated neurodegeneration, we profiled miRNA expression and identified selective miRNAs, including miR-277, that are
altered specifically in Drosophila brains expressing rCGG repeats. We tested their genetic interactions with rCGG repeats and
found that miR-277 can modulate rCGG repeat-mediated neurodegeneration. Furthermore, we identified Drep-2 and Vimar
as functional targets of miR-277 that could modulate rCGG repeat-mediated neurodegeneration. Finally, we found that
hnRNP A2/B1, an rCGG repeat-binding protein, can directly regulate the expression of miR-277. These results suggest that
sequestration of specific rCGG repeat-binding proteins could lead to aberrant expression of selective miRNAs, which may
modulate the pathogenesis of FXTAS by post-transcriptionally regulating the expression of specific mRNAs involved in
FXTAS.
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Introduction
Fragile X syndrome (FXS), the most common form of inherited
mental retardation, is caused by expansion of the rCGG
trinucleotide repeat in the 59 untranslated region (59 UTR) of
the fragile X mental retardation 1 (FMR1) gene, which leads to
silencing of its transcript and the loss of the encoded fragile X
mental retardation protein (FMRP) [1–6]. Most affected individ-
uals have more than 200 rCGG repeats, referred to as full
mutation alleles [7]. Fragile X syndrome carriers have FMR1
alleles, called premutations, with an intermediate number of
rCGG repeats between patients (.200 repeats) and normal
individuals (,60 repeats) [8]. Recently, the discovery was made
that male and, to a lesser degree, female premutation carriers are
at greater risk of developing an age-dependent progressive
intention tremor and ataxia syndrome, which is uncoupled from
fragile X syndrome and known as fragile X-associated tremor/
ataxia syndrome (FXTAS) [9,10]. This is combined with cognitive
decline associated with the accumulation of ubiquitin-positive
intranuclear inclusions broadly distributed throughout the brain in
neurons, astrocytes, and in the spinal column [11,12].
At the molecular level, the premutation is different from either
the normal or full mutation alleles. Based on the observation of
significantly elevated levels of rCGG-containing FMR1 mRNA,
along with either no detectable change in FMRP or slightly
reduced FMRP levels in premutation carriers, an RNA-mediated
gain-of-function toxicity model has been proposed for FXTAS
[13–17]. Several lines of evidence in mouse and Drosophila models
further support the notion that transcription of the CGG repeats
leads to this RNA-mediated neurodegenerative disease
[11,15,17–19]. The hypothesis is that specific RNA-binding
proteins may be sequestered by overproduced rCGG repeats in
FXTAS and become functionally limited, thereby contributing to
the pathogenesis of this disorder [15,17,19,20]. There are three
RNA-binding proteins found to modulate rCGG-mediated
neuronal toxicity: Pur a, hnRNP A2/B1, and CUGBP1, which
bind rCGG repeats either directly (Pur a and hnRNP A2/B1) or
indirectly (CUGBP1, through the interaction with hnRNP A2/
B1) [21,22].
MicroRNAs (miRNAs) are small, noncoding RNAs that
regulate gene expression at the post-transcriptional level by
targeting mRNAs, leading to translational inhibition, cleavage of
the target mRNAs or mRNA decapping/deadenylation [23,24].
Mounting evidence suggests that miRNAs play essential functions
in multiple biological pathways and diseases, from developmental
timing, fate determination, apoptosis, and metabolism to immune
response and tumorigenesis [25–31]. Recent studies have shown
that miRNAs are highly expressed in the central nervous system
(CNS), and some miRNAs have been implicated in neurogenesis
and brain development [32–34].
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expanded to encompass their roles in neurodegeneration.
Investigators have begun to reveal the influence of miRNAs
on both neuronal survival and the accumulation of toxic
proteins that are associated with neurodegeneration, and are
uncovering clues as to how these toxic proteins can influence
miRNA expression [35]. For example, miR-133b is found to
regulate the maturation and function of midbrain dopaminergic
neurons (DNs) within a negative feedback circuit that includes
the homeodomain transcription factor Pitx3 in Parkinson’s
disease [36]. In addition, reduced miR-29a/b-1-mediated
suppression of BACE1 protein expression contributes to Ab
accumulation and Alzheimer’s disease pathology [37]. More-
over, the miRNA bantam is found to be a potent modulator of
poly-Q- and tau-associated degeneration in Drosophila [38].
Other specific miRNAs have also been linked to other
neurodegenerative disorders, such as spinocerebellar ataxia
type 1 (SCA1) and Huntington’s disease (HD) [39,40].
Therefore, miRNA-mediated gene regulation could be a novel
mechanism, adding a new dimension to the pathogenesis of
neurodegenerative disorders.
Here we show that fragile X premutation rCGG repeats can
alter the expression of specific miRNAs, including miR-277, in a
FXTAS Drosophila model. We demonstrate that miR-277
modulates rCGG-mediated neurodegeneration. Furthermore,
we identified Drep-2, which is associated with the chromatin
condensation and DNA fragmentation events of apoptosis, and
Vimar, a modulator of mitochondrial function, as two of the
mRNA targets regulated by miR-277. Functionally, Drep-2 and
Vimar could modulate the rCGG-mediated neurodegeneration,
as well. Finally, we show that hnRNP A2/B1, an rCGG repeat-
binding protein, can directly regulate the expression of miR-277.
These data suggest that hnRNP A2/B1 could be involved in the
transcriptional regulation of selective miRNAs, and fragile X
premutation rCGG repeats could alter the expression of specific
miRNAs, potentially contributing to the molecular pathogenesis
of FXTAS.
Results
Fragile X premutation rCGG repeats alter the expression
of selective miRNAs
Given the important roles of miRNAs in neural development
and human neurological disorders, we investigated the role of
miRNAs in rCGG-mediated neurodegeneration. To determine
whether fragile X premutation rCGG repeats could influence the
expression of miRNAs, we profiled the expression of 72 known
miRNAs using rCGG repeat transgenic flies that we generated
previously [15]. In rCGG repeat transgenic flies, the severity of
their phenotype depends on both dosage and length of the rCGG
repeat. Moderate expression of (CGG)90 repeats exclusively in the
eyes have an effect on morphology and histology; however,
expression of (CGG)90 repeats in the neurons leads to lethality at
the embryonic stage, preventing analysis at the adult stage [15].
Therefore, we used a shorter repeat length, r(CGG)60, which
allowed us to examine the gene expression in adults. To analyze
the effect of rCGG repeats in adult brains, we used RNAs isolated
from the age- and sex-matched brains of control flies (elav-GAL4)
and flies expressing rCGG60 repeats in neurons (elav-GAL4;UAS-
CGG60-EGFP) for miRNA profiling experiments (Figure 1). We
identified a subset of miRNAs that consistently displayed altered
expression in rCGG repeat flies versus the control group. Seven
miRNAs with a $two-fold increase and two miRNAs with
expression decreased by $1.5-fold have been found in rCGG
repeat flies. These results suggest that fragile X premutation
rCGG repeats could lead to the dysregulation of a subset of
specific miRNAs.
Overexpression of miR-277 enhances rCGG-mediated
neurodegeneration
To assess the potential involvement of the miRNAs that showed
altered expression in FXTAS fly brain, we examined the genetic
interaction between specific miRNAs and rCGG-mediated
neuronal toxicity based on the fragile X premutation rCGG
repeat-mediated neurodegenerative eye phenotype we observed
previously [15]. We generated UAS fly lines that could overexpress
Drosophila miR-277, bantam, let-7, or miR-1, as well as bantam
mutant lines (ban
12 and ban
20) that we generated previously [41].
We then crossed these transgenic lines with gmr-GAL4, UAS-
(CGG)90-EGFP transgenic flies that exhibit photoreceptor neuro-
degeneration to determine the role of specific miRNAs in rCGG-
mediated neurodegeneration. As shown in Figure 2, flies co-
expressing miR-277 and rCGG90 consistently showed an aggra-
vated eye phenotype, with enhanced disorganized, fused omma-
tidia compared with flies expressing rCGG90 alone (Figure 2B and
2D). Flies overexpressing miR-277 alone displayed a very mild
rough eye phenotype (Figure 2C). Alterations of the levels of
bantam, let-7, or miR-1 by either a gain of function or loss of
function had no effect on rCGG-mediated neurodegeneration
(Figure 2E–2N). These data together suggest that miR-277 could
be involved in rCGG-mediated neurodegeneration. The role of
miR-277 in rCGG-mediated neurodegeneration seems specific,
since the other miRNAs we found with altered expression in the
presence of fragile X premutation rCGG repeats, including
bantam, let-7, and miR-1, had no effect on the rCGG90 eye
phenotype. The rest of our work focused on the role of miR-277
and its potential mechanisms in modulating rCGG-mediated
neurodegeneration.
Blocking the activity of miR-277 suppresses rCGG-
mediated neurodegeneration
Our miRNA profiling and genetic interaction studies indicated
that an increase in miR-277 expression in rCGG repeat flies
could alter the expression of specific cellular mRNAs by miR-
277, resulting in the enhanced rCGG-induced eye phenotype. To
further explore the potential regulatory effect of miR-277 on
rCGG-mediated neurodegeneration, we generated a transgenic
miR-277 sponge (miR-277SP) line, which could block the activity
Author Summary
Fragile X–associated tremor/ataxia syndrome (FXTAS) is an
adult-onset neurodegenerative disorder, usually affecting
males over 50 years of age. FXTAS patients are the carriers
of fragile X premutation alleles. Using a FXTAS Drosophila
model, we previously demonstrated that fragile X pre-
mutation rCGG repeats alone could cause neurodegener-
ation. Pur a and hnRNP A2/B1 were identified as specific
premutation rCGG repeat-binding proteins (RBPs) that
could bind and modulate fragile X permutation rCGG-
mediated neuronal degeneration. MiRNAs are sequence-
specific regulators of post-transcriptional gene expression.
Here we show that fragile X premutation rCGG repeats
could lead to aberrant expression of selective miRNAs,
which may modulate the pathogenesis of FXTAS by post-
transcriptionally regulating the expression of specific
mRNAs involved in FXTAS.
miRNAs in FXTAS
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neurodegenerative eye phenotype. We generated the miRNA
sponge transgenic construct as described previously [42,43]. In
brief, we placed 10 repetitive sequences complementary to miR-
277 with mismatches at positions 9–12 into the 39 UTR of EGFP
in a pUASP expression vector (Figure 3A). We crossed miR-
277SP transgenic flies with the flies expressing 90 CGG repeats
and found that the expression of miR-277 sponge could
consistently suppress rCGG-mediated neuronal toxicity
(Figure 3B). MiR-277 sponge alone or scramble control sponge
had no effect on eye morphology (Figure 3B and Data not
shown). This result suggests that blocking the activity of miR-277
could mitigate the neurodegeneration caused by fragile X
premutation rCGG repeats.
Identification of miR-277 mRNA targets that modulate
rCGG-mediated neurodegeneration
To seek the mechanisms by which miR-277 modulates rCGG-
mediated neurodegeneration, we searched the RNA network and
referenced TargetScanFly 5.1 to identify potential miR-277 targets
[44,45]. We selected the top candidates for miR-277 target
mRNAs with the mutant alleles available for further analyses
(Table 1). We then carried out a genetic screen on the rCGG90
neurodegenerative eye phenotype to identify potential miR-277
Figure 1. Identification of the miRNAs with altered expression in the brains of an FXTAS Drosophila model. Relative quantity of miRNA
with $two-fold change in expression shown for rCGG60 flies, calibrated to control (elav-GAL4) flies. Control relative quantity=1.
doi:10.1371/journal.pgen.1002681.g001
Figure 2. Overexpression of miR-277 enhances rCGG-mediated neurodegeneration. Shown are scanning electron microscope (SEM) eye
images from seven-day-old flies. WT fly eyes show the normal organization of ommatidia (A). Expression of rCGG90 causes disorganized, fused
ommatidia (B). Flies overexpressing miR-277 alone present with a mild rough eye phenotype (C). The rCGG90 eye phenotype is enhanced by miR-277
overexpression with aggravated disorganized, fused ommatidia (D). Alteration of bantam, let-7, or miR-1 does not modify the rCGG-induced eye
phenotype (F, H, J, L, N). Alteration of bantam, let-7 or miR-1 alone does not cause an abnormal eye phenotype (E, G, I, K, M). Genotypes are B-gmr-
GAL4,UAS-CGG90-EGFP/+;C -gmr-GAL4/UAS-miR-277;D -gmr-GAL4, UAS-CGG90-EGFP/UAS-miR-277;E - gmr-GAL4/+;UAS-bantam/+;F - gmr-GAL4,UAS-CGG90-
EGFP/+;UAS-bantam/+;G - gmr-GAL4/+;UAS-Let-7/+;H - gmr-GAL4,UAS-CGG90-EGFP/+;UAS-Let-7/+;I - gmr-GAL4/UAS-GFP;UAS-miR-1/+;J - gmr-GAL4,UAS-
CGG90-EGFP/UAS-GFP;UAS-miR-1/+;K - gmr-GAL4/+;ban
12/+;L - gmr-GAL4,UAS-CGG90-EGFP/+;ban
12/+;M - gmr-GAL4/+;ban
20/+;N - gmr-GAL4,UAS-CGG90-
EGFP/+;ban
20/+.
doi:10.1371/journal.pgen.1002681.g002
miRNAs in FXTAS
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We crossed gmr-GAL4, UAS-(CGG)90-EGFP transgenic flies with fly
mutants in genes coding for the top candidates for miR-277 target
genes (Table 1). The progenies were then tested for potential
suppression or enhancement of the disorganized eye phenotype
versus flies expressing rCGG90 alone. Through this screen, we
identified two modifiers of rCGG-mediated neurodegeneration,
Drep-2 and Vimar. As shown in Figure 4, partial loss of Drep-2
could enhance the rCGG90 eye phenotype by increasing
ommatidial disorganization (Figure 4B). Overexpression of Drep-
2 could suppress the rCGG-induced eye phenotype (Figure 4C).
Flies carrying the Drep-2 mutation alone or Drep-2 overexpres-
Figure 3. Blocking the activity of miR-277 suppresses rCGG-mediated neurodegeneration. A. Shown is the diagram depicting the
strategy for generation of transgenic microRNA sponge lines. The sponge construct contains 10 repetitive sequences complementary to a microRNA
downstream of EGFP in a UAS-containing P-element vector. When these UAS lines are crossed to GAL4 driver lines, the F1 progeny generate tissue- or
cell-specific expression of microRNA sponge to block the activity of specific miRNA in Drosophila. B. The miR-sponge contains bulged sites that are
mismatched opposite microRNA at positions 9–12. The bulge is designed to protect Ago2-mediated endonucleolytic cleavage. C. Scanning electron
microscope (SEM) eye images from seven-day-old flies. Block of miR-277 activity by miR-277SP could rescue the rCGG-mediated neurodegenerative
eye phenotype. Knockdown of miR-277 alone does not cause an abnormal eye phenotype. Genotypes are (left)-gmr-GAL4,UAS-CGG90-EGFP/+;
(middle)-gmr-GAL4,UAS-CGG90-EGFP/UAS-miR-277SP; (right)-gmr-GAL4/UAS-miR-277SP.
doi:10.1371/journal.pgen.1002681.g003
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found a heterozygous loss-of-function mutant of Vimar that
aggravated the rCGG90 eye phenotype (Figure 4F). Eyes of control
flies carrying the same Vimar mutation but no rCGG90 repeats are
normal (Figure 4G). These data together indicate that Drep-2 and
Vimar could modulate rCGG-mediated neurodegeneration.
MiR-277 regulates the expression of Drep-2 and Vimar
post-transcriptionally
Since both Drep-2 and Vimar were predicted to be regulated by
miR-277, by introducing 39-UTR dual luciferase assays, we tested
whether miR-277 could indeed target to Drep-2 or Vimar. We
cloned the 39-UTR of Drep-2 or Vimar containing the predicted
miR-137 target sites from fly cDNA into a dual luciferase (R-Luc
and F-Luc) reporter construct, allowing for the assessment of
protein translation of these targets regulated via their 39-UTR
(Figure 5A). These 39-UTR dual constructs were transfected into
HEK293 cells. We found that overexpression of miR-277 could
suppress the R-Luc activity at 48 h post-transfection (Figure 5B
and 5C). Furthermore, when we mutated the seed regions of miR-
277 located within the Drep2-39-UTR reporter and Vimar-39-
UTR reporter, we saw that the mutation alleviated the miR-277-
mediated suppression of luciferase activity (Figure 5A–5C),
suggesting the action of miR-277 is specific to the miR-277 seed
region within the Drep-2 39-UTR and Vimar 39-UTR. Together,
these data demonstrate that the effect of miR-277 on Drep-2 and
Vimar expression is repressive and specific. Importantly, they also
suggest that Drep-2 and Vimar are the functional targets of miR-
277.
Next we went on to examine the steady-state levels of Drep-2
and Vimar mRNA in rCGG repeat flies (elav-GAL4;UAS-CGG60-
EGFP), in which the expression of miR-277 is increased. We saw a
significant reduction of endogenous Drep-2 mRNA in rCGG
repeat flies relative to control flies (elav-GAL4), whereas the Vimar
mRNA expression in rCGG repeat flies remained similar to
control flies (elav-GAL4) (Figure 5D). Furthermore, ectopic
expression of miR-277 or miR-277 sponge could alter the
endogenous mRNA level of Drep2 while have no apparent effect
on Vimar mRNA level (Figure 5E). These observations suggest
that miR-277 could regulate Drep-2 and Vimar mRNAs
differentially, with miR-277 regulating the expression of Drep-2
mainly at the mRNA level, and Vimar via translational
suppression instead.
Expression of miR-277 is regulated by the rCGG repeat-
binding protein hnRNP A2/B1
Two rCGG repeat-binding proteins, Pur a and hnRNP A2/B1,
were previously found to bind rCGG repeats directly and
modulate rCGG-mediated neuronal toxicity [21,22]. Intriguingly,
recent studies have shown that multiple heterogeneous nuclear
Table 1. Mutant alleles corresponding to the mRNA targets of miR-277 used for genetic screen.
Gene Alleles Potential function
Polypeptide GalNAc transferase 5 (Pgant5) pgant5
B480 Oligosaccharide biosynthetic process
Frizzled (Fz) fz
EY03114 Wnt receptor activity
CG5599 CG5599
KG02236 Dihydrolipoamide branched chain acyltransferase activity
Netrin-B (NetB) NetB
KG03586 Motor axon guidance, salivary gland boundary specification
CG32767 CG32767
BG01357 Nucleic acid binding
Decapping protein 2 (Dcp2) Dcp2
BG01766 RNA binding, hydrolase activity, manganese ion binding
Belphegor (Bor) bor
c05496 Nucleoside-triphosphatase activity, ATP binding
CG3267 CG3267
e02164 Methylcrotonoyl-CoA carboxylase activity, CoA carboxylase
activity
DNA fragmentation factor-related protein 2 (Drep-2) Drep-2
KG02396
Drep-2
d00223
Apoptosis, neurogenesis
GTPase-activating protein 1 (Gap1) Gap1
B2 Ras GTPase activator activity
G protein oa 47A (G-oa47A) G-oa47A
01 GTP binding
CG1673 CG1673
EP1023 Branched-chain-amino-acid transaminase activity
Abrupt (Ab) ab
k02807 Sequence-specific DNA binding transcription factor activity
Visceral mesodermal armadillo-repeats (Vimar) vimar
k16722 Ral GTPase binding, modulator of mitochondrial function
Scribbled (scrib) scrib
j7B3 Protein binding, post-embryonic organ morphogenesi
Flotillin 2 (Flo-2) Flo-2
BG01945 Cell adhesion
Synaptotagmin b (Sytb) Sytb
BG02150 Calcium-dependent phospholipid binding
Starry night (stan) stan
f00907 Receptor signaling protein activity
Scully (scu) scu
f05851 NADP+ activity
CG15093 CG15093
d04924 Cellular amino acid metabolic process
CG18265 CG18265
EY11347 Zinc ion binding
Gliotactin (Gli) Gli
EY11600 Carboxylesterase activity
Elbow B (Elb) elB
3 Zinc ion binding, nucleic acid binding
Cirl Cirl
EY12930 Latrotoxin receptor activity
Task6 Task6
EY23668 Potassium channel activity
doi:10.1371/journal.pgen.1002681.t001
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protein 1 (HP1) to bind to genomic DNA and modulate
heterochromatin formation [46]. Thus we tested whether hnRNP
A2/B1 could interact directly with genomic regions proximal to
miR-277. We performed hnRNP A2/B1-specific chromatin
immunoprecipitation (ChIP) followed by real-time quantitative
PCR across a six-kb region surrounding miR-277. Immunopre-
cipitation of chromatin chemically cross-linked to DNA with an
hnRNP A2/B1-specific antibody demonstrated that a region
1.5 kb upstream of miR-277 was enriched ,seven-fold relative to
Figure 4. Modification of rCGG-mediated neurodegenerative eye phenotype by Drep-2 and Vimar. (A–C) SEM eye images from control
flies expressing rCGG90, rCGG90 and a heterozygous mutation in Drep-2 (Drep-2
LOF), rCGG90 and overexpression of Drep-2 (Drep-2
OE), and rCGG90 and
a heterozygous mutation in Vimar (Vimar
LOF). rCGG90 flies manifest ommatidial disorganization and fusion (A). This phenotype is enhanced in flies
carrying a heterozygous loss-of-function mutation in Drep-2 (B), while the eye phenotype could be suppressed by overexpression of Drep-2 (C).
Mutation of Vimar enhances the rCGG90-mediated eye phenotype (F). All the mutants alone do not cause any abnormal eye phenotype (D, E, G).
Genotypes are A-gmr-GAL4,UAS-CGG90-EGFP/+;B- gmr-GAL4, UAS-CGG90-EGFP/Drep-2
KG02396;C - gmr-GAL4, UAS-CGG90-EGFP/Drep-2
d00223;D - gmr-GAL4/
Drep-2
KG02396;E - gmr-GAL4/ Drep-2
d00223;F- gmr-GAL4, UAS-CGG90-EGFP/ Vimar
K16722;G - gmr-GAL4/ Vimar
K16722.
doi:10.1371/journal.pgen.1002681.g004
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more, the ectopic expression of hnRNP A2/B1 in fly brain could
reduce the expression of miR-277 (Figure 6C). These results
together suggest that hnRNP A2/B1 could directly bind to the
upstream region of miR-277 and regulate its expression. In the
presence of fragile X premutation rCGG repeats, hnRNP A2/B1
will be sequestered, leading to the de-repression of the miR-277
locus.
Discussion
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a
neurodegenerative disorder that afflicts fragile X syndrome
premutation carriers, with earlier studies pointing to FXTAS as
an RNA-mediated neurodegenerative disease. Several lines of
evidence suggest that rCGG premutation repeats may sequester
specific RNA-binding proteins, namely Pur a, hnRNP A2/B1,
and CUGBP1, and reduce their ability to perform their normal
cellular functions, thereby contributing significantly to the
pathology of this disorder [15,21,22]. The miRNA pathway has
been implicated in the regulation of neuronal development and
neurogenesis [32,47–49]. A growing body of evidence has now
revealed the role of the miRNA pathway in the molecular
pathogenesis of neurodegenerative disorders [35]. Here we
demonstrate that specific miRNAs can contribute to fragile X
rCGG repeat-mediated neurodegeneration by post-transcription-
ally regulating target mRNAs that are involved in FXTAS. We
show that miR-277 plays a significant role in modulating rCGG
Figure 5. MiR-277 regulates the expression of Drep-2 and Vimar post-transcriptionally. A. The two miR-277 target sites in the Drep-2 39-
UTR and three miR-277 target sites in the Vimar 39-UTR were predicted by TargetScan. We created the mutant Drep-2 39-UTR (Drep-2 39-UTR
DmiR-277)
with two miR-277 binding sites deleted and the mutant Vimar 39-UTR (Vimar 39 UTR
DmiR-277) with three miR-277 binding sites deleted, as shown. B.
The expression of a luciferase reporter gene containing the Drep-2 39-UTR was suppressed by miR-277 in HEK293FT cells. The suppression is specific
to the miR-277 seed region within the Drep-2 39-UTR, as deletion of the miR-277 target sites in the Drep-2 39-UTR alleviated repression by miR-277.
(*-P,0.05; ns-P.0.05). C. Similar miR-277-mediated suppression was observed with Vimar 39-UTR constructs. D. Endogenous Drep-2 mRNA
expression was significantly reduced in rCGG repeat flies relative to control flies (elav-GAL4), whereas no obvious change of Vimar mRNA expression
was observed in the rCGG repeat flies compare to control flies. E. Endogenous Drep-2 mRNA expression was significantly altered in the flies
expressing either miR-277 or miR-277 SP, *-P,0.05.
doi:10.1371/journal.pgen.1002681.g005
miRNAs in FXTAS
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enhances rCGG repeat-induced neuronal toxicity, whereas
blocking miR-277 activity could suppress rCGG repeat-mediated
neurodegeneration. Furthermore, we identified Drep-2 and Vimar
as the functional miR-277 targets that could modulate rCGG
repeat-induced neurodegeneration. Finally, we show that hnRNP
A2/B1, an rCGG repeat-binding protein, can directly regulate the
expression of miR-277. Our biochemical and genetic studies
demonstrate a novel miRNA-mediated mechanism involving miR-
277, Drep-2, and Vimar in the regulation of neuronal survival in
FXTAS (Figure 7).
Several lines of evidence from studies in mouse and Drosophila
models strongly support FXTAS as an RNA-mediated neurode-
generative disorder caused by excessive rCGG repeats [11,15,17–
19]. The current working model is that specific RNA-binding
proteins could be sequestered by overproduced rCGG repeats in
FXTAS and become functionally limited, thereby contributing to
the pathogenesis of this disorder [15,17,19,20]. Three RNA-
binding proteins are known to modulate rCGG-mediated
neuronal toxicity: Pur a, hnRNP A2/B1, and CUGBP1, which
bind rCGG repeats either directly (Pur a and hnRNP A2/B1) or
indirectly (CUGBP1, through the interaction with hnRNP A2/
B1) [21,22]; how the depletion of these RNA-binding proteins
could alter RNA metabolism and contribute to FXTAS
pathogenesis has thus become the focus in the quest to
understand the molecular pathogenesis of this disorder. Never-
theless, the data we present here suggest that the depletion of
hnRNP A2/B1 could also directly impact the transcriptional
regulation of specific loci, such as miR-277. We know that
hnRNPs can interact with HP1 to bind to genomic DNA and
modulate heterochromatin formation [46]. Our results indicate
that hnRNP A2/B1 could participate in the transcriptional
regulation of miR-277; however, it remains to be determined
whether other loci could be directly regulated by hnRNP A2/B1,
as well. Identifying those loci will be important to better
understand how the depletion of rCGG repeat-binding proteins
could lead to neuronal apoptosis.
In recent years, several classes of small regulatory RNAs have
been identified in a range of tissues and in many species. In
particular, miRNAs have been linked to a host of human diseases.
Some evidence suggests the involvement of miRNAs in the
emergence or progression of neurodegenerative diseases. For
example, accumulation of nuclear aggregates that are toxic to
neurons have been linked to many neurodegenerative diseases,
and miRNAs are known to modulate the accumulation of the toxic
proteins by regulating either their mRNAs or the mRNAs of
proteins that affect their expression. Moreover, miRNAs might
contribute to the pathogenesis of neurodegenerative disease
downstream of the accumulation of toxic proteins by altering the
expression of other proteins that promote or inhibit cell survival
[35]. Our genetic modifier screen revealed that miR-277 could
modulate rCGG repeat-mediated neurodegeneration. By combin-
ing our genetic screen and reporter assays, we identified Drep-2
and Vimar as the functional targets of miR-277 that could
modulate rCGG-mediated neurodegeneration. The closest ortho-
log of miR-277 in human is miR-597 based on the seed sequence.
It would be interesting to further examine the role of miR-597 in
FXTAS using mammalian model systems.
Drep-2 is associated with the chromatin condensation and DNA
fragmentation events of apoptosis [50,51]. Drep-2 is one of four
Drosophila DFF (DNA fragmentation factor)-related proteins. While
Drep-1 is a Drosophila homolog of DFF45 that can inhibit CIDE-A
mediated apoptosis [50]. Drep-2 has been shown to interact with
Drep-1 and to regulate its anti-apoptotic activity [50]. Vimar is a
Ral GTPase-binding protein that has been shown to regulate
mitochondrial function via an increase in citrate synthase activity
[52]. In the presence of fragile X premutation rCGG repeats,
overexpression of miR-277 will suppress the expression of both
Drep-2 and Vimar, thereby altering anti-apoptotic activity as well
as mitochondrial functions, which have been linked to neuronal
cell death associated with neurodegenerative disorders in general
(Figure 7). Interestingly, we saw a significant reduction of Drep-2
mRNA in the flies expressing rCGG repeats, while Vimar mRNA
levels remained similar to control flies. This observed difference
Figure 6. Expression of miR-277 is regulated by hnRNPA2/B1. A. Schematic of the six kb proximal to miR-277 on chromosome 3R assayed in
ChIP experiments. B. HnRNP A2/B1-specific ChIP assay indicates the enrichment of DNA 1.5 kb upstream of the miR-277 genomic locus. Relative
enrichment is calculated relative to IgG-only nonspecific control and normalized to the empty vector. Error bars indicate mean 6 SEM. C. Ectopic
expression of hnRNP A2/B1 in fly brain could suppress the expression of miR-277, *-P,0.05.
doi:10.1371/journal.pgen.1002681.g006
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modes of action, including mRNA cleavage, translational
inhibition and mRNA decapping/deadenylation its target mRNAs
[23,24].
In summary, here we provide both biochemical and genetic
evidence to support a role for miRNA and its selective mRNA
targets in rCGG-mediated neurodegeneration. Our results suggest
that sequestration of specific rCGG repeat-binding proteins can
lead to aberrant expression of selective miRNAs that could
modulate the pathogenesis of FXTAS by post-transcriptionally
regulating the expression of specific mRNAs involved in this
disorder. Identification of these miRNAs and their targets could
reveal potential new targets for therapeutic interventions to treat
FXTAS, as well as other neurodegenerative disorders.
Materials and Methods
Drosophila genetics
All flies were maintained under standard culture conditions. The
rCGG repeat transgenic flies (UAS-CGG60-EGFP and UAS-CGG90-
EGFP) were generated in our lab as described previously [15]. Flies
mutant in genes coding for different candidate miR-277 targets were
obtained from Bloomington Stock Center. The UAS-miR-277-Sponge
transgenic flies were generated as described previously [43]. We
introduced 10 repetitive miR-277 sponge sequences (TGTCGTAC-
CAGGCGTGCATTTA) with a 4-nt linker between each repeat
downstream of EGFP in a pUASP expression vector. Similarly a
scramble control construct (GTTCACGGATAGTGCCTGTACT)
was generated as well. Both constructs were confirmed by DNA
sequencing and then injected in the w
1118 strain by standard methods.
Relative quantification of mature miRNAs by TaqMan
miRNA real-time PCR
Total RNAs were isolated from the control (elav-GAL4) and
rCGG60 fly heads using Trizol. TaqMan MicroRNA Assays
detecting 72 known individual Drosophila miRNAs were obtained
from ABI (ABI). cDNA was prepared with High-Capacity cDNA
Reverse Transcription Kits (ABI; Cat#437496). The 15-ml reverse
transcription reactions consisted of 10 ng of total RNA, 5 U
MultiScribe Reverse Transcriptase, 0.5 mM of each dNTP, 16
reverse transcription buffer, 4 U RNase inhibitor, and nuclease-
free water. This was performed at 16uC for 30 min and at 42uC
for 30 min, terminated at 85uC for 5 min and 4uC until use in
TaqMan assays. For real-time PCR of TaqMan MicroRNA
Assays, we used 0.5 ul 206TaqMan MicroRNA Assay Primer,
1.33 ul undiluted cDNA, 5 ul 26TaqMan Universal PCR Master
Mix, 3.17 ul nuclease-free water. Each PCR reaction was
performed in triplicate with MicroAmp optical 96-well plates
using a 7500 Fast Real-Time PCR System (ABI), with reactions
incubated at 95uC for 10 min, followed by 40 cycles of 95uC for
15 s, and 60uC for 1 min. Fluorescence readings were taken
during the 60uC step. RQs were calculated using the DDCt
method, with 2S RNA TaqMan miRNA control assay as the
endogenous control, and calibrated to the control samples.
Quantitative RT–PCR
The fly heads from control (elav-Gal4) and rCGG60 flies were
collected. Trizol (Invitrogen; Cat# 15596-026) was used to isolate
total RNA from each genotype. RNA samples were reverse-
transcribed into cDNA with oligo(dT)20 and SuperScript III
(Invitrogen; Cat#18080051). Real-time PCR was performed with
gene-specific primers and Power SYBR Green PCR Master Mix
(Applied Biosystems; Cat# 4367660) using the 7500 Standard
Real-Time PCR System (Applied Biosystems). RpL32 (Qiagen;
Cat# QT00985677) was used as an endogenous control for all
samples. Primers for Drep2 and Vimar transcripts were designed
using Primer Express 3.0 software (Applied Biosystems) and were
as follows. Drep2: forward, 59-TGGAACGCCTCAACTCCAA-
39; and reverse, 59-TCGGACTCGCGATCCAA-39. Vimar:
forward, 59-GCACCCGCCGAACAGA-39; and reverse, 59-
Figure 7. Proposed model of miR-277 modulating fragile X premutation rCGG repeat-mediated neurodegeneration. HnRNP A2/B1, an
rCGG repeat-binding protein, could be sequestered by fragile X premutation rCGG repeats from their normal cellular functions. Sequestration of
hnRNP A2/B1 could de-repress the expression of miR-277. MiR-277 could recognize and bind to the 39-UTR of its mRNA targets, such as Drep-2 and
Vimar, to induce their mRNA degradation or translational suppression. Misregulation of Drep-2 or Vimar, which are involved in cell apoptosis or
mitochondrial regulation, could lead to the neuronal cell death associated with FXTAS.
doi:10.1371/journal.pgen.1002681.g007
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reactions were performed in triplicate, and RQs were calculated
using the DDCt method, with calibration to control samples.
39-UTR dual luciferase assays of candidate miR-277 target
mRNA
Drep-2 39-UTR and Vimar 39-UTR sequences were PCR-
amplified directly from w
1118 fly brain first-strand cDNA
generated from 5 ug TRIZOL-isolated total RNA using oligo-
dT SuperScript III reverse transcription according to the
manufacture’s protocol (Invitrogen; Cat. #1808-093). The PCR
products were then cloned into psiCHECK-2 dual luciferase
vector (Promega; Cat# C8021). The miR-277 target sites in the
Drep-2 39-UTR and Vimar 39-UTR were deleted using
QuikChange Site-Directed Mutagenesis Kits (Stratagene; Cat.
#2000518). Target sites deletions were verified by Genewiz
sequencing. Briefly, 293FT cells were co-transfected by Attractene
transfection reagent (Qiagen; Cat. #301005) with psiCHECK-2-
39UTR or psiCHECK-2-39 UTRDmiR-277 and miR-277 duplex
RNA (Qiagen; Cat# MSY0000338) or control miRNA duplex
(Qiagen; Cat# 1027280). All co-transfections used a total of
600 ng of plasmid DNA and 120 nmol of duplex RNA. Luciferase
expression was detected using the Dual-Luciferase Reporter 1000
System (Promega; Cat# E1980) according to the manufacturer’s
instructions. At 48 h after transfection, R-Luc activity was
normalized to F-Luc activity to account for variation in
transfection efficiencies, and miR-277-mediated knockdown of
R-Luc activity was calculated as the ratio of normalized R-Luc
activity in the miR-277 duplex treatments to normalized R-Luc
activity in the negative control duplex treatments. Luciferase
experiments were repeated three times.
Chromatin immunoprecipitation (ChIP)
ChIP was performed using a ChIP Assay Kit (Millipore). S2
cells were cross-linked with 1% formaldehyde (Sigma-Aldrich) for
10 min at room temperature. Chromatin was fragmented to an
average size of 500 bp by sonication (Sonicator 3000; Misonix)
and immunoprecipitated with anti-Flag M2 antibody (sigma).
Immunoprecipitated and purified DNA fragments were diluted to
1 ng/ml in nuclease-free water. We used 8 ng of DNA in 20-ml
SYBR Green real-time PCR reactions consisting of 16 Power
SYBR Green Master Mix and 0.5 mM forward and reverse
primers. Reactions were run on an SDS 7500 Fast Instrument
(Applied Biosystems). Primers were designed using Primer Express
3.0 software (Applied Biosystems) and were as follows. 4.5 kb
upstream: forward, 59-CAGAAAACAGGCGTGCAAAC; and
reverse, 59-GAATTTGCATTGGCTTTGGAA. 3.5 kb up-
stream: forward, 59- TTACAATTGGATGGGCTTCGT; and
reverse, 59-AAGCTGACGGCCTGACTAAAAA. 2.5 kb up-
stream: forward, 59-GTTGGCTGCTGCGTCAATT; and re-
verse, 59- GCCCCAGCGGCATTTATA. 1.5 kb upstream:
forward, 59- TTCTGGCACTGGCAGCTTT; and reverse, 59-
CATCGTGCTGGCCAACAC. 1.0 kb upstream: forward, 59-
TGTACGGGCATGTGTATGCA; and reverse, 59- TCAAC-
GAACACGCTGCGTAT. 0.5 kb upstream: forward, 59- GG-
GCATTTTCATTTCATTCCA; and reverse, 59- CGGGC-
AGCGTAATTTAAGCT. 0.5 kb downstream: forward, 59- CG-
CCCACAAGAGCTTTTGA; and reverse, 59- TTTCCACGG-
TATGCTGCTTTT. 1.5 kb downstream: forward, 59- CGTT-
TCCATTTAGTTGGATTTTTGT; and reverse, 59- GGCAA-
ACCACACATTTTAACATACA. DNA relative enrichment was
determined by taking the absolute quantity ratios of specific IPs to
nonspecific IPs (normal mouse IgG only), IP/IgG, and normal-
izing to control (pUAST only). Independent chromatins were
prepared for all ChIP experiments, and real-time PCR reactions
were performed in triplicate for each sample on each amplicon.
Scanning electron microscopy
For scanning electron microscopy (SEM) images, whole flies
were dehydrated in gradient concentration ethanol (25%, 50%,
75%, 100%), dried with hexamethyldisilazane (Sigma; Cat#
16700), and analyzed with an ISI DS-130 LaB6 SEM/STEM
microscope.
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